SCHEMBL3397270

SCHEMBL3397270

CC(=O)Nc1ccc(C(=O)Nc2cnc(Nc3ccc(F)cc3)s2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN11 Q06124 2/20 0.50
PTPN1 P18031 2/20 0.50
PTPN6 P29350 1/20 0.50
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
AGER Q15109 1/20 0.49
KCNQ3 O43525 1/20 0.49
KCNQ2 O43526 1/20 0.49
KCNE1 P15382 1/20 0.49
KCNQ1 P51787 1/20 0.49
BACE1 P56817 1/20 0.49
P4HTM Q9NXG6 2/20 0.48
MEN1 O00255 2/20 0.48
POLB P06746 2/20 0.48
KMT2A Q03164 2/20 0.48
HDAC1 Q13547 2/20 0.47
HDAC3 O15379 1/20 0.47
HDAC2 Q92769 1/20 0.47
NCOR2 Q9Y618 1/20 0.47
NOS1 P29475 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3393541 0.89 CACNA1B (0.56) NPC1RAB9AAGERMEN1POLB
SCHEMBL3398555 0.89 RAB9A (0.55) NPC1RAB9AAGERP4HTMMEN1
SCHEMBL3398551 0.88 POLB (0.49) NPC1RAB9AAGERMEN1POLB
SCHEMBL3393588 0.86 CSNK2A2 (0.55) NPC1RAB9AP4HTMPOLBKMT2A
SCHEMBL3393963 0.83 NAMPT (0.56) NPC1RAB9APOLBKMT2AHDAC1
SCHEMBL3397155 0.79 CSNK2A2 (0.60) NPC1RAB9AP4HTMMEN1POLB
SCHEMBL2367264 0.76 TNIK (0.72) POLB
SCHEMBL3393872 0.74 CSNK2A2 (0.52) NPC1RAB9AP4HTMMEN1POLB
SCHEMBL3394933 0.74 CSNK2A2 (0.60) NPC1RAB9AMEN1POLBKMT2A
SCHEMBL3397141 0.73 CSNK2A2 (0.51) NPC1RAB9AMEN1POLBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100216795-A1 TNIK INHIBITOR AND THE USE YAMADA TESSHI 2010-08-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100216795-A1 TNIK INHIBITOR AND THE USE TNIK, TNNI3K, TNK1 PTPN11 414/4885PTPN1 393/4885PTPN6 399/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.